STS
REGN icon

SG Trading Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

SG Trading Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.08M Buy
+3,992
New +$2.71M 0.72% 26

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SG Trading Solutions's REGN Position: Q4 2025 in Review

SG Trading Solutions opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2025: 3,992 shares worth $3.08M. The stake represents 0.72% of the portfolio and ranks #26 among its holdings.

1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • SG Trading Solutions held 3,992 shares of Regeneron Pharmaceuticals worth $3.08M as of Q4 2025.
  • Regeneron Pharmaceuticals was a new SG Trading Solutions position in Q4 2025.
  • Regeneron Pharmaceuticals made up 0.72% of SG Trading Solutions's portfolio in Q4 2025, its #26 holding.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on SG Trading Solutions's 13F filing for Q4 2025, filed 24 Feb 2026.